Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications
Authors:
- Stuart K. RobertsSRStuart K. Roberts
- John C. ColmanJCJohn C. Colman
- Eldho PaulEPEldho Paul
- Peter ButtonPBPeter Button
- William KempWKWilliam Kemp
- 26 January 2015
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 50 (4) , 462-469
Abstract
Clinically significant portal hypertension (CSPH) is associated with increased risk of liver disease complications, but its identification requires invasive methods. Liver stiffness (LS) measurement via transient elastography correlates with the presence of CSPH. We, therefore, evaluated LS as a noninvasive tool in the prediction of CSPH and portal hypertensive complications. Ninety-five consecutive patients successfully underwent measurement of hepatic venous pressure gradient (HVPG) and LS on the same day. Recent laboratory tests were correlated. Patients were followed up for development of portal hypertensive complications. Predictors of CSPH and complications were identified. Seventy-six (80%) were male and mean age was 56.8 ± 9.3 years. Ninety-three percent and 72% of patients had cirrhosis and esophageal varices, respectively. Only LS (r(2) = 0.38; p < 0.0001) and international normalized ratio (r(2) = 0.21; p = 0.02) were independently associated with HVPG. An LS >29.0 kilopascal (kPa) predicted CSPH with 71.9% sensitivity, 100% specificity, 100% positive predictive value (PPV), and 56.0% negative predictive value (NPV). An LS 150 × 10(9)/L excluded CSPH with 91.7% sensitivity, 100% specificity, 100% PPV, and 90% NPV. Ninety patients were followed up for a median duration of 15.1 months. CSPH and LS >34.5 kPa predicted portal hypertensive complications with 100% and 75.0% sensitivity, 40.3% and 69.4% specificity, 43.1% and 52.5% PPV, and 100% and 86.2% NPV, respectively. LS shows promise as a noninvasive marker of CSPH and portal hypertensive complications. Combining LS with platelet count improves diagnostic accuracy in the exclusion of CSPH.Keywords
This publication has 29 references indexed in Scilit:
- Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated CirrhosisGastroenterology, 2013
- Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosisJournal of Hepatology, 2009
- Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosisAlimentary Pharmacology & Therapeutics, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver diseaseAlimentary Pharmacology & Therapeutics, 2008
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008
- Hepatic Venous Pressure Gradient and Outcomes in CirrhosisJournal of Clinical Gastroenterology, 2007
- Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡Hepatology, 2007
- Beta-Blockers to Prevent Gastroesophageal Varices in Patients with CirrhosisNew England Journal of Medicine, 2005
- Transient elastography: a new noninvasive method for assessment of hepatic fibrosisUltrasound in Medicine & Biology, 2003